Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 405 is a genetic element classified as an rRNA pseudogene, specifically part of the 5S ribosomal RNA family but with mutations or deletions that prevent it from giving rise to a functional RNA product[4]. Pseudogenes are gene sequences that have lost their protein-coding or functional RNA-producing ability due to evolutionary changes and are generally non-coding. This specific pseudogene, like others in the 5S ribosomal RNA pseudogene family, arises from duplication and subsequent loss of function. They are not considered therapeutic targets, do not produce functional molecules, and are not implicated in disease or used as biomarkers. There is no evidence in the current scientific literature (including functional genomics databases and GENCODE/Ensembl annotation) that RNA, 5S ribosomal pseudogene 405 serves a biological role, interacts with drugs, or is involved in known disease mechanisms[4]. No canonical functions, disease associations, drug interactions, or biomarker uses are described for this pseudogene. The designation, aliasing, and format provided in the query are correct for a pseudogene, but RNA5SP405 is not a real target for therapeutic intervention or mechanistic studies. Its inclusion as a "target" would be considered incorrect. RNA, 5S ribosomal pseudogene 405 is a non-coding, non-functional, pseudogene not supported as a therapeutic target, biomarker, or disease mechanism. Any listing as a drug target would be incorrect[4].
None reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 405 (RNA5SP405).